Matthew S. Green

Matthew S. Green has extensive experience in finance and operations management in the pharmaceutical and healthcare industries. Matthew S. is currently working as the Vice President and Head of Finance at Aquestive Therapeutics, where they are responsible for financial analysis across various functions and supports capital transactions and business development transactions. Prior to this role, they served as the Head of Corporate M&A, Treasury, and Risk Management at RailWorks Corporation from 2017 to 2020. Matthew S. also held leadership positions at West-Ward Pharmaceuticals, Caris Life Sciences, Par Pharmaceutical, Schering Plough, and Johnson & Johnson, where they gained experience in commercial operations, finance planning and analysis, marketing, and financial planning. Matthew's experience demonstrates their expertise in financial analysis, business development, commercial strategy, and corporate transactions.

Matthew S. Green obtained a MBA degree in Marketing & Finance from New York University from 2002 to 2004. Prior to that, they attended Penn State University, where they earned a BS degree in Finance & Economics. There is no information about their educational background before college. Additionally, they hold a certification in CMA from IMA.